Mourenza
It was first developed in 1991 as a derivative of Body Protection Compound, a peptide naturally found in human gastric juices [1, 2]
Tolerance, a term meaning that after continued drinking, increasing amounts of alcohol are necessary to produce the same effect, does not have an effect on the actual BAC.
Di Lazzaro V, Molinari M, Restuccia D, Leggio MG, Nardone R, Fogli D, et al
In a 2001 study published in Endocrinology , Heffernan and colleagues reported that chronic AOD-9604 administration reduced body weight gain, decreased adipose tissue mass, and increased fat oxidation in obese mice without altering IGF-1 levels or glucose metabolism effects that were abolished in beta3 adrenergic receptor (3-AR) knockout mice, implicating 3-AR signaling as the mechanism of action [1]